Oncology The fire and ice of oncolytic virotherapy In the language of immuno-oncology (IO), the terms “hot” and “cold” refer to tumours that are inflamed or non-inflamed, respectively.
News ADARx, Trex, and Retension take aim at IPOs The appetite among biotechs for IPOs shows no signs of being satisfied, with three more – ADARx, TRex, and Retension – making their intentions known.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
